Color and contrast-specific perimetry to probe retinal ganglion cell subtype vulnerability
This audio article is from VisualFieldTest.com (https://visualfieldtest.com) . Read the full article here: https://visualfieldtest.com/en/color-... Test your visual field online: https://visualfieldtest.com Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/su... Excerpt: Introduction Vision relies on many kinds of retinal ganglion cells (RGCs), each tuned to different color or contrast signals. Standard visual field tests use white-on-white (achromatic) stimuli and measure overall sensitivity, but early or selective damage in diseases like glaucoma can hide behind normal full-field results. Specialized perimetry tests now probe specific pathways by using color or temporal contrast stimuli. For example, blue-on-yellow perimetry (Short-Wavelength Automated Perimetry, SWAP) presents a bright blue target on a yellow background to isolate the short-wavelength (blue) cone pathway and its small bistratified RGCs (). Similarly, red–green (chromatic) tests aim at the long-/medium-wavelength cone pathways (parvocellular system), and flicker/temporal tests (like frequency-doubling perimetry or high-frequency flicker) stress the large parasol (magnocellular) RGCs. By dissecting vision in this way, clinicians hope to catch damage in specific RGC subtypes earlier or more precisely than with white-on-white testing. This article reviews these color- and contrast-specific perimetry methods and how they relate to glaucoma and optic nerve disease. We discuss what blue-yellow and red-green perimetry can reveal about pathway dysfunction, how flicker perimetry examines temporal contrast processing, and how these functional losses map onto structural imaging (OCT) and blood flow metrics (OCT-Angiography). We also consider evidence on whether such targeted tests predict later decline on standard fields, and suggest practical testing protocols that maximize diagnostic insight without overly straining patients. Color- and Contrast-Specific Perimetry Blue–Yellow (SWAP) Perimetry Blue-on-yellow perimetry (SWAP) is a well-known color test. It uses a large, narrowband blue stimulus (around 440 nm) presented on a bright yellow background (). The high-luminance yellow field adapts the red and green cones so that the remaining pathway – the short-wavelength (blue) cones and their small bistratified RGCs – respond mainly. In effect, SWAP “isolates” the blue-cone channel. Early glaucoma often affects these small bistratified cells, so SWAP can reveal field loss sooner than conventional testing (). Indeed, studies report SWAP can detect visual field defects in glaucoma suspects or early glaucoma eyes before standard perimetry shows losses, suggesting higher sensitivity for early damage () (). For example, one study found SWAP deficits strongly correlated with retinal nerve fiber thinning (r≈0.56 in the inferior quadrant) in glaucoma patients (), indicating SWAP loss matches structural damage. However, SWAP has practical limitations. It is sensitive to lens opacity (cataracts make results unreliable) and generally requires longer testing (to overcome adaptation effects). Clinically, SWAP often uses a “SITA-SWAP” algorithm to shorten time, but patients may still fatigue easily. In research, SWAP fields have shown greater mean deficits than white-on-white fields in glaucoma suspects () (), but reproducibility can be an issue. Another SWAP-based approach measures pupil responses (pupillography) to blue vs yellow stimuli, reflecting melanopsin ganglion cell function. One study found blue-light pupillary tests detected early loss slightly better than yellow-light stimuli in mild g Support the show (https://www.buzzsprout.com/2563091/su...)

Inequities in access to visual field testing and their outcome consequences

Something is jamming GPS over Europe. Here's what we found

The Insane Genius of a Formula 1 Gearbox

Nicotinamide and NAD+ Boosting for Glaucoma Neuroprotection and Healthy Aging

Appointment before Cataract Surgery | Discussion about astigmatism, IOLs, Laser, Insurance, & more.

But what is quantum computing? (Grover's Algorithm)

Low-Carb Diets and Nocturnal Blood Pressure Dips: Ocular Perfusion Risks and Benefits

Glaucoma and Glutamine: Is There a Real Link Through Glutamate, Retinal Metabolism, and Neurodege...

Delta Pilot Arrested 20 Minutes Before Departure

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

7.2 - Humphrey Visual Field

You're Doing Push-Ups Wrong... This Is Why You're Not Getting Stronger

HOW TO READ AN OCT PRINTOUT IN GLAUCOMA || BASIC TESTING PROTOCOLS|| ( RNFL, ONH & MACULAR ANALYSIS}

The Crystal That Could Destroy All Medicine

Brain Imaging Biomarkers and Plasticity in Glaucoma

Therapeutic Mechanisms Debuting in April 2026 Glaucoma Trials

Trabeculectomy vs Tube Shunts in the Modern Era: Long-Term Safety and Durability

Macular OCT Interpretation: A Practical Discussion with Dr. David E. Lederer

Cataract Surgery Lenses Options - MD Explains BEST Lens Choice in 2026

